can semaglutide cause heart problems weight loss drugs like Ozempic or Wegovy problems? Dr. Mallika Marshall answers your questions GLP-1 Agonists in Cardiovascular Diseases:

Experimental protocol The whole period of study was eight weeks

Both compounded and brand-name versions carry similar side effect profiles and require the same medical supervision

10.1126/science.aba3683 179 YuL.HuX.XuR.ZhaoY.XiongL.AiJ.et al (2024)

Whos qualified for GLP-1 Bridge program To be eligible, a patient must meet one of these three conditions: Have a body mass index (BMI) of 35 or more Have a BMI between 30-34.99 and at least one of these conditions: Diastolic heart failure (also called heart failure with preserved ejection fraction) Uncontrolled hypertension (high blood pressure) Chronic kidney disease at stage 3a or higher Prediabetes A previous heart attack or stroke Peripheral artery disease with symptoms Or, have a BMI between 27-29.99 and at least one of these conditions: Prediabetes A previous heart attack (also called myocardial infarction) or stroke Blocked arteries in your legs or arms (also called peripheral artery disease) with symptoms Patients are not eligible if they fall into these categories: If they already are covered for a GLP-1 through Part D Have type 2 diabetes, moderate-to-severe sleep apnea, or fatty liver disease, in which case, they may already be covered by their Part D plans This article first appeared on Bridge Michigan and is republished here under a Creative Commons Attribution-NoDerivatives 4.0 International License

While compounded medications are not FDA-approved, they are legally manufactured and prescribed by licensed physicians for individual patient needs